
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 39.820 | 60.020 | 20.200 |
Shares | 58.850 | 58.850 | 0.000 |
Bonds | 1.300 | 1.300 | 0.000 |
Preferred | 0.010 | 0.010 | 0.000 |
Other | 0.020 | 0.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.802 | 11.866 |
Price to Book | 2.334 | 1.534 |
Price to Sales | 1.600 | 2.034 |
Price to Cash Flow | 8.386 | 10.178 |
Dividend Yield | 2.475 | 6.300 |
5 Years Earnings Growth | 10.897 | 12.097 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 19.400 | -29.508 |
Technology | 17.630 | 5.248 |
Financial Services | 14.900 | 55.780 |
Industrials | 10.230 | 12.568 |
Consumer Cyclical | 9.150 | 10.048 |
Consumer Defensive | 7.640 | 7.468 |
Communication Services | 6.040 | 4.344 |
Energy | 5.400 | 16.775 |
Basic Materials | 4.080 | 15.044 |
Utilities | 2.930 | 15.086 |
Real Estate | 2.590 | 11.899 |
Number of long holdings: 21
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares Core MSCI World UCITS | IE00B4L5Y983 | 55.91 | 120.88 | -1.49% | |
SPDR S&P Biotech | US78464A8707 | 3.28 | 91.99 | +2.38% | |
Tesouro IPCA + NTNB 6 15-May-2045 | BRSTNCNTB0A6 | 0.75 | 3,790.630 | +0.00% | |
ARX BNY Liquidez FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez VIII FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez X FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez VII FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez VI FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez V FI RF Ref DI | - | 0.06 | - | - | |
ARX BNY Liquidez IX FI RF Ref DI | - | 0.06 | - | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review